We did find an association with factor Xa inhibitor use and lower incidence of alcohol- and smoking-related cancers, lung cancer, hematological cancer, and gastroesophageal cancer, suggesting that factor Xa may play a role in cancer progression in specific cancer types. This evidence concerns the gene F10 and lung cancer.